Golouh Valentin, Kobilica Nina, Breznik Silva
Department of Radiology, University Medical Centre Maribor, Maribor, SVN.
Department of Vascular Surgery, University Medical Centre Maribor, Maribor, SVN.
Cureus. 2020 Sep 18;12(9):e10527. doi: 10.7759/cureus.10527.
Drug-coated balloon angioplasty may present an efficient alternative to traditional balloon angioplasty and stenting, which suffer from high rates of restenosis and increased risk of stent fractures in the anatomically unfavorable regions, such as the superficial femoral artery in the adductor canal. Although pseudoaneurysms are the most common vascular access site complications, they are considerably rarer at the site of the endovascular treatment. They can be caused by several mechanisms, including stent fractures, usage of oversized balloons, high-pressure inflations, and infections. In addition, paclitaxel, the drug released from drug-coated balloons, may also play a significant role in the formation and exacerbation of pseudoaneurysms. The exact pathophysiology remains unclear, but it may be due to a combination of paclitaxel's suppression of neointimal healing and immune response, cytotoxic properties, and hypersensitivity-related inflammation.
药物涂层球囊血管成形术可能是传统球囊血管成形术和支架置入术的一种有效替代方法,传统方法在诸如内收肌管内的股浅动脉等解剖结构不利区域存在较高的再狭窄率和支架断裂风险。尽管假性动脉瘤是最常见的血管穿刺部位并发症,但在血管内治疗部位则相当罕见。它们可由多种机制引起,包括支架断裂、使用过大的球囊、高压扩张和感染。此外,药物涂层球囊释放的药物紫杉醇也可能在假性动脉瘤的形成和加重中起重要作用。确切的病理生理机制尚不清楚,但可能是由于紫杉醇抑制内膜愈合和免疫反应、细胞毒性特性以及过敏相关炎症共同作用的结果。